Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Cancer Immunol Res. 2014 Jun 17;2(9):890–900. doi: 10.1158/2326-6066.CIR-13-0199-T

Figure 1.

Figure 1

IL-32 is highly expressed in MF lesional skin. A–C, IL-32 mRNA levels using skin (VL; healthy volunteers, MF / patch stage, plaque stage, tumor stage, Pso, AD). Data in Fig. 1C are from a different experiment than those in Fig. 1A–B. Horizontal bars are mean ± SD. *P<0.05, ***P<0.001. D, Immunohistochemistry for IL-32 using skin from VL and MF patients (patch, plaque, and tumor stage). Arrows show cells positive for IL-32. Magnification, ×200 (left panels) and ×400 (right panels). Scale bar represents 100μm.